Roles of the transforming growth factor β1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: Results of an immunohistochemical study

Journal of Surgical Oncology

Volumn 64, Issue 4, 1997, Pages 262-267

  Takanami, Iwao ^a,c   Tanaka, Fumihiko ^a   Hashizume, Toshinori ^b   Kodaira, Susumu ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b Kanagawa National Hospital   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

prognostic factor; proliferation; signal transduction; tumor progression

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR GROWTH;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030965529     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199704)64:4<262::AID-JSO3>3.0.CO;2-7     Document Type: Article

References (24)

1. Massague J: The transforming growth factor-β family. Ann Rev Cell Biol 6:597-614,1990.
2. Sporn MB, Roberts AB: The transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119:1017-1021,1992.
3. Sporn MB, Torando GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878-880,1980.
4. Miyazono K, Hellman U, Wernstedt C, Heldine CH: Latent high molecular weight complex of transforming growth factor β1. J Biol Chem 263:6407-6415,1988.
5. Kingsley DM: The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146,1994.
6. Wrana JL, Attisano L, Wieser R, et al.: Mechanism of activation of the TGF-β receptor. Nature 370:341-347,1994.
7. Lopex-Casillas F, Wrana JL, Massague J: Betaglycan presents ligand to the TGF-β signaling receptor. Cell 73:1435-1444,1993.
8. Travis WD, Travis LB, Devesas SS: Lung cancer. Cancer 75:191-202,1995.
9. Valaitis J, Warren S, Gamble D: Increasing incidence of adenocarcinoma of the lung. Cancer 47:1042-1047,1981.
10. Hirayama D, Fujimori T, Satonaka K, et al.: Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastric cancer. Hum Pathol 23:681-685,1992.
11. Jasani B, Wyllie FS, Wright PA, et al.: Immunohistochemically detectable TGF-β is associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2;149-155,1990.
12. Johnson MD, Federspiel CF, Gold LI, Moses HL: Transforming growth factor-β and transforming growth factor β receptor expression in human meningioma cell. Am J Patho 141:633-642,1992.
13. Gorsch SM, Memoli VA, Stukel TA, et al.: Immunohistochemical staining for transforming growth factor β1 associates with disease progression human breast cancer. Cancer Res 52:6949-6952,1992.
14. Takanami I, Imamura T, Hashizume T, et al.: Transforming growth factor β1 as a prognostic factor in pulmonary adenocarcinoma. J Clin Pathol 47:1094-1100,1994.
15. Friess H, Yamanaka Y, Büchler M, et al.: Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846-1856,1993.
16. Friess H, Yamanaka Y, Büchler M, et al.: Enhanced expression of the type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 53:2104-2707,1993.
17. Yamada N, Kato M, Yamashita H, et al.: Enhanced expression of transforming growth factor-β (TGF-β) and its type I and type II receptors in human glioblastoma. Int J Cancer 62:386-392,1995.
18. Fulls D, Brockmeyer D, Tullous MW, et al.: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674-679,1992.
19. Sherr CJ: The ins and out of RB: coupling gene expression to the cell-cycle clock. Trends Cell Biol 4:15-18, 1994.
20. Pietenpol JA, Munber K, Howley PM, et al.: Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor β1 and by the retinoblastoma gene products. Proc Nat Acad Sci 88:10227-10231,1991.
21. Tateishi M, Ishida T, Mitsudomi T, et al.: Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res 50:7077-7080,1990.
22. Tateishi M, Ishida T, Mitsudomi T, et al.: Prognostic implication of transforming growth factor a in adenocarcinoma of the lung-an immunohistochemical study. Br J Cancer 63:130-133,1991.
23. Tateishi M, Ishida T, Mitsudomi T, et al.: Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27:1372-1375,1991.
24. Takanami I, Tanaka F, Hashizume T, et al.: Expression of basic fibroblast growth factor and its receptor are involved in the progression of pulmonary adenocarcinoma. Eur J Cancer 32A:1504-1509,1996.